Detalhe da pesquisa
1.
Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.
Liver Int
; 44(2): 286-292, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38131512
2.
Clinical profile of Spanish hepatitisC virus-infected treatment-naïve patients with compensated cirrhosis in the CREST study. / Perfil clínico de los pacientes españoles con hepatitisC naïve con cirrosis compensada tratados en el estudio CREST.
Gastroenterol Hepatol
; 2024 Feb 13.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38355095
3.
Low risk of viral hepatitis amongst patients with severe mental disorders.
Liver Int
; 43(6): 1204-1212, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041668
4.
Benefits of using exchangeable copper and the ratio of exchangeable copper in a real-world cohort of patients with Wilson disease.
J Inherit Metab Dis
; 46(5): 982-991, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254446
5.
Recent advances in the diagnosis and management of Wilson's disease.
Rev Esp Enferm Dig
; 115(10): 539-541, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37073691
6.
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Gut
; 71(3): 593-604, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741640
7.
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules.
J Hepatol
; 76(4): 874-882, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856322
8.
Considerations for optimizing Wilson's disease patients' long-term follow-up. / Enfermedad de Wilson: consideraciones para optimizar el seguimiento a largo plazo.
Gastroenterol Hepatol
; 45(2): 146-154, 2022 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-34052403
9.
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.
J Hepatol
; 74(5): 1064-1074, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278456
10.
Efficacy of an accelerated double-dose hepatitis B vaccine regimen in patients with cirrhosis.
J Viral Hepat
; 28(7): 1019-1024, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763966
11.
Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy.
J Viral Hepat
; 28(1): 89-94, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969557
12.
Elastography is unable to exclude cirrhosis after sustained virological response in HCV-infected patients with advanced chronic liver disease.
Liver Int
; 41(11): 2733-2746, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525253
13.
Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response.
Liver Int
; 41(12): 2954-2964, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34242479
14.
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025.
J Hepatol
; 73(6): 1360-1367, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32697948
15.
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
J Hepatol
; 72(3): 472-480, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629779
16.
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.
J Hepatol
; 73(6): 1415-1424, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535060
17.
Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8+ T cells after direct-acting antiviral therapies.
J Viral Hepat
; 27(12): 1408-1418, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32812325
18.
Low seroprevalence and zero incidence rate of hepatitis E in men who have sex with men during a hepatitis A outbreak.
J Med Virol
; 92(8): 1359-1362, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31743439
19.
Improvement of sexuality after hepatitis C cure with direct acting antivirals.
Liver Int
; 40(12): 2972-2977, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025664
20.
Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals.
J Gastroenterol Hepatol
; 35(9): 1570-1578, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31957902